2026 International Congress » Parkinson's disease: Neuroimaging

18F-FD4 PET Reveals α-Synuclein Deposition and Clinical Correlations in Parkinson’s Disease

JW. Wang (Shanghai, China)

7 Tesla MRI with Quantitative Susceptibility Mapping: Quantitative focal measurements and qualitative grading of the substantia nigra as a biomarker for Parkinson’s Disease

R. Unsgård, K. Stige, A. Kristoffersen, P. Goa, C. Tzoulis, E. Berntsen (Trondheim, Norway)

A Dopamine Clock for Biological Staging of Parkinson’s Disease

R. Gunn, G. Searle, G. Rizzo, Z. Fan, T. Tropea, T. Simuni, K. Poston, A. Siderowf, L. Chahine, J. Seibyl, K. Marek (London, United Kingdom)

Active Contact Localization in the Subthalamic Nucleus Predicts Phonemic Fluency Decline After Bilateral STN-DBS

š. Janovič, S. Hollý, B. Al-Fatly, P. Zvarová, M. Kľoc, T. Harag, M. Chmelík, D. Juskanič, L. Hapáková, A. Kušnírová, B. Gaštanová, Z. Košutzká (Bratislava, Slovakia)

Altered Degree Centrality and Its Association with Neurotransmitter Systems in Parkinson’s Disease Patients with Impulse Control Disorders: A Resting-State fMRI Study

X. Wang, Y. Yuan (Nanjing, China)

Altered local synchronization and functional connectivity in Patients with Parkinson’s Disease

DH. Lee (Wonju, Republic of Korea)

Amyloid Burden in the Precuneus and Posterior Cingulate Gyrus Is Associated With Cognitive Function and White Matter Microstructure in Lewy Body Dementia

H. Takeshige-Amano, N. Nishikawa, M. Osawa, H. Okada, D. Kamiyama, K. Onuki, S. Takemoto, K. Takabayashi, K. Kamagata, K. Murakami, T. Kato, T. Hatano, N. Hattori (Tokyo, Japan)

Association of Glymphatic Flow at Diffusion Tensor Image with Motor Symptoms and Striatal Dopamine Degeneration in Parkinson’s Disease

SJ. Chung, CJ. Park, PH. Lee, YH. Sohn, YJ. Kim (Seoul, Republic of Korea)

Attention-Enhanced Deep Learning for Midbrain MRI Segmentation in Parkinson’s Disease

C. Mahapatra, S. Swain (Powai, India)

Automated Differentiation for Early Parkinsonism Using Clinical Structural MRI: A Multicenter Study

LC. Zhou, CZ. Wang, AL. Du, J. Liu, J. Wang (Shanghai, China)

Automated MRI Biomarker Extraction for Parkinson’s Disease Using Attention-Based U-Net Segmentation

G. Kuanar, C. Mahapatra (Cuttack, India)

Basal Ganglia Lacunar Infarcts and Risk of Mortality and Dementia in Parkinsonism: A Population-Based Study

L. Malfer, F. Onorati, A. Mullan, R. Savica (Rochester, USA)

Basal Ganglia Pathway Recruitment Determines Bidirectional Bradykinesia Modulation by DBS in Humans

P. Navratil, A. Schmidt, H. Eldebakey, N. Rajamani, V. Odekerken, R. de Bie, C. Zhang, K. Kimura, G. Abbas, R. Peach, J. Roothans, J. Volkmann, F. Lange, M. Reich (Wuerzburg, Germany)

Baseline assessment of nigrostriatal integrity via VMAT2 PET in participants with Parkinson’s disease from the BIIB122/DNL151 LUMA Phase 2b study

A. Hone-Blanchet, R. Llorens-Arenas, B. Hersh, O. Mabrouk, J. Dubois, D. Jennings, M. Clarke, A. Wittington, M. Wald, D. Graham, M. Hutchison (Cambridge, USA)

Baseline MRI Predictors of Phenoconversion and Prodromal Progression in Non-Manifesting PD Mutation Carriers: A Longitudinal Retrospective Analysis

AD. Droby, BK. Krayem, SA. Abed, NN. Nguyen, DE. Eidelberg, AV. Vo, AM. Mirelmen, AT. Thaler (Tel Aviv, Israel)

Beyond Motor Symptoms: Utilizing the FreeSurfer Brainstem Substructures Module to Characterize a Complex Parkinsonian Phenotype with Profound Dysautonomia

M L. Chin, A K. Lee (Ipoh, Malaysia)

Cerebellar cholinergic denervation relates to impaired gait and cerebellocortical resting-state functional connectivity in Parkinson disease

B. Maiti, J. O'Donnell, K. Rawson, M. Owusu-Ansah, A. Tannenbaum, A. Eid, S. Grossen, J. Hood, S. Norris, M. Campbell, G. Earhart, J. Perlmutter (Saint Louis, USA)

Cerebellar Network Compensation in Parkinson’s Disease: Functional Connectivity Across Motor and Cognitive Circuits

C. Lin, T. Magalhães, S. Yonce, I. Rampalli, R. Mahabir, J. Bernard (Houston, USA)

Cerebellar peduncle microstructure and autonomic dysfunction in Parkinson’s disease

RY. Yang, YUZ. Zhang (Guangzhou, Guangdong Province, China)

Cerebellar-Basal Ganglia Circuitry in the Pathogenesis of Parkinsonian Postural Instability

O. Alenikova, A. Chumak, L. Parkhach (Minsk, Belarus)

Cholinergic Dysconnectivity in Early Parkinson’s Disease Aligns with the Basal Forebrain Functional Gradient

A. Ignatavicius, L. Churchill, A. Konuri, J. Anderson, S. Lewis, E. Matar (Macquarie Park, Australia)

Cholinergic dysfunction associated to aberrant functional connectivity in Parkinson Disease-related dystonia

L. Xavier, A. Morris, N. Goldman, J. O’Donnell, A. Magee, A. Eid, H. Hwang, J. Perlmutter, M. Campbell, S. Norris (Saint Louis, USA)

Cholinergic Pathway Degeneration Predicts Differential Phenoconversion to Synucleinopathies in Idiopathic REM Sleep Behavior Disorder

D. Zhang, T. Wu (Beijing, China)

Clinical and brain morphological characteristics of patients with Parkinson’s disease and co-occurring apathy and impulse control disorders

S. Prange, E. Metereau, M. Bereau, H. Klinger, C. Caire, C. Laurencin, D. Devos, M. Anheim, S. Thobois (Bron, France)

Clinical Significance of Automatically Assessed Perivascular Space Count in Subcortical White Matter of Parkinson’s Disease

SJ. Chung, CJ. Park, Y. Nam, YJ. Kim, PH. Lee (Seodaemun-gu, Republic of Korea)

Clinical Utility of DaT-SPECT as a Predictive Tool for the Development of Parkinson’s Disease and Related ɑ-synucleinopathies in REM-Behavior Disorder

M. Markgraf, H. Bhaskar, O. Lekan-Michael, D. Lubin, M. Lammle (Syracuse, USA)

Comparison of Neuroimaging-Derived and Clinical Motor Subtypes in Early Parkinson’s Disease

L. Saadatpour, A. Vijayakumari, K. Sakaei, D. Teixeira-Dos-Santos, H. Fernandez, B. Walter (San Antonio, USA)

Comparison of Subcortical Brain Volumes in Different At-risk Cohorts of Parkinson’s Disease – Preliminary Data from the MUMFORD Study.

F. Jagusch, S. Leiter, A. Droby, A. Mirelman, K. Marini, C. Theyer, V. Sidoroff, C. Horlings, M. Aktan-Süzgün, A. Stefani, B. Högl, R. Steiger, A. Grams, E. Gizewski, C. Scherfler, B. Heim, K. Seppi, P. Mahlknecht, F. Krismer, A. Thaler (Innsbruck, Austria)

Correlations Between Clinical Variables And Cerebral Perfusion in Parkinson’s Disease With Mild Cognitive Impairment: A Multi-Delay pcASL Study

N. Chaurasiya, G. Rathi, V. Mishra (Birmingham, USA)

Cortical Oscillatory Dynamics during Turning in Parkinson’s Disease using OPM-MEG

P. Sharma, B. Sanders, C. Gilmartin, L. Rier, L. Gascoyne, J. Leggett, I. Tu, M. Dabbagh, H. Pai, L. Eriamietor, N. Holmes, R. Hill, E. Boto, A. Hibbert, H. Schofield, K. Mullinger, K. Radford, A. Fasano, M. Brookes, N. Evangelou (Nottingham, United Kingdom)

Cortical–Subcortical Structural Signature of dementia with lewy bodies Reveals Cognitive Trajectories of Lewy Body Disease in REM Sleep Behavior Disorder

JH. Shin, HJ. Kim, JY. Lee (Seoul, Democratic People's Republic of Korea)

Coupling between global BOLD signal and cerebrospinal fluid flow in isolated REM sleep behavior disorder and its relation with non-motor symptoms.

C. Martín-Barceló, I. Roura, R. Sala-Llonch, C. Falcon, J. Pardo, C. Garcia-Vicente, L. Pacheco-Jaime, N. Bargalló, M. Serradell, G. Mayà, A. Montini, M. Buongiorno, C. Gaig, C. Junqué, A. Iranzo, B. Segura (Barcelona, Spain)

Data-driven Longitudinal Trajectories of Hippocampal Volume in Parkinson’s Disease and Across the Neurodegenerative Disease Spectrum

U. Saeed, S. E Black, C. Marras, M. A Binns, D. P Breen, K. N Fishman, D. A Grimes, B. Levine, P. M Mclaughlin, A. K Troyer, R. Bartha, H. Zetterberg, A. E Lang, M. Masellis (Toronto, Canada)

Deep learning-derived progression network in isolated REM sleep behavior disorder

N. Nguyen, A. Vo, S. Peng, D. Truong, P. Wu, C. Zuo, J. Lee, Y. Ma, D. Eidelberg (Shanghai, China)

Default Mode Network Co-Activation Pattern Dynamics and Their Relationship to Cognition in Parkinson’s Disease with and without Mild Cognitive Impairment

P. Chunchu, N. Singhal, T. Davis, V. Mari, V. Mishra (Birmingham, USA)

Diffusion MRI Evidence of Cerebellar Involvement in Cognitive Dysfunction in Parkinson’s Disease

A. Vijayakumari, L. Saadatpour, D. Floden, K. Sakaie, H. Kaur, H. Fernandez, B. Walter (Cleveland, USA)

Disease Endophenotyping through Graph and Adjacency Metrics (DEGAS): Network Biomarkers for Parkinson’s Disease Prognosis

A. Martinez-Nunez, M. Okun, J. Wong (Gainesville, USA)

Disparate Subregional Striatal DAT-SPECT Associations with CSF-Synucleinopathy Status and Clinical Severity Across Parkinson’s Disease Continuum

AD. Droby, BK. Krayem, AM. Mirelman, AT. Thaler (Tel Aviv, Israel)

Distinct Cortical and Subcortical Network Mechanisms of High and Low Frequency Subthalamic Stimulation in Parkinsons Disease

Z. Zeng, Z. Lin, C. Zhang, Z. Duan, B. Sun, N. He, P. Peng, D. Li (Shanghai, China)

Distinct Glymphatic Pathways Underlie Prodromal and Clinical Features of Parkinson’s Disease

J. Choi, M. Kim, A. Kim (Los Angeles, USA)

Distinct Local and Global Functional Network Reorganization Underlying STN versus GPi DBS in Parkinson’s Disease

H. Ding, K. Xie, B. Bahners, W. He, J. Chen, M. Metzger, B. Nasseroleslami, J. Volkmann, D. Li, M. Muthuraman, C. Zhang (Würzburg, Germany)

Distinct Patterns of Perivascular Diffusivity and Choroid Plexus Volume in De Novo Parkinson’s Disease and Type 2 Diabetes

YJ. Bae, C. Shin, H. Jeong, SJ. Cho, SH. Baik, DH. Lee, Y. Jeong, JM. Kim (Gainesville, USA)

Does PET Imaging Modality Influence Artificial Intelligence Performance in Diagnosing Parkinson’s Disease? Diagnostic Test Accuracy Meta-analysis

MH. Elkasaby, MSA. Ahmed (Cairo, Egypt)

Dopaminergic reconfiguration of an inverted network hierarchy in Parkinson’s disease

Z. Zhang, T. Feng (Beijing, China)

Drivers of Navigated Walking Performance in Aging and Parkinson’s Disease: Insights From Behavioral Clustering, Clinical and Neuroimaging Data

A. Kvist, L. Bezuidenhout, H. Johansson, U. Ekman, D. Moulaee Conradsson, F. Albrecht, E. Franzén (Stockholm, Sweden)

DTI-ALPS index and its association with dopamine loss, brain metabolism, and motor and cognitive manifestations in Parkinson’s disease

HS. Yoo, CH. Lyoo, YH. Ryu, M. Park (Seoul, Republic of Korea)

DTI-ALPS Insights into Glymphatic Dynamics and Neurovascular Changes in Parkinson’s Disease

G. Yılmaz çakan, A. Bayram, B. Samancı, G. Kızılateş Evin, L. Karşıgil, G. Kenangil, A. Zırh, Y. Samancı (Istanbul, Turkey)

DTI-Based Comparative Analysis of Microstructural Alterations in Parkinson Disease and Atypical Parkinsonism

H. Lin, W. Dai (Urumqi, China)

Dynamic Neural States underlying Freezing of Gait in Parkinson’s Disease

Y. Tian, E. Matar, S. Berkovsky, S. Lewis (North Ryde, Australia)

Effect of ApoE ε4 allele on brain metabolism and cognition in non-demented Parkinson’s disease

JH. Lee, YH. Ryu, CH. Lyoo, HS. Yoo (Seoul, Republic of Korea)

Electrocardiographic Indicators of Autonomic Dysfunction in Parkinson’s Disease: A Scoping Review and Meta-analysis

I. Serag, A. Negida (Mansoura, Egypt)

Examining the Impact of Fatigue on White Matter tracts in Parkinson’s Disease

JY. Park, E. Morales, J. Bedime, C. Mvomo, S. Perfetto, F. Parent-L’Ecuyer, I. Sierra, H. Lajeunesse, A. Parent, M. Sharp, A. Rochette, A. Potvin-Desrochers, C. Paquette (Montreal, Canada)

Exploratory study of brain 5-HT4 receptor availability in early-stage Parkinson’s disease

S. Hassen, C. Castano, S. Bourdon, AE. Vallet, A. Lepetit, J. Xie, J. Redoute, V. Sgambato (Vienne, France)

FDG-PET-Based Machine Learning Differentiates Parkinson’s Disease from Other Neurodegenerative Disorders

B. Song, P. Turcano, K. Ghoniem, C. Piat, E. Camerucci, J. Bower, L. Barnard, D. Jones, R. Savica (Rochester, USA)

fMRI Activity during Working Memory Manipulation is Associated with Caudate Integrity in Early Parkinson’s Disease

K. Giehl, H. Theis, A. Asendorf, M. Banwinkler, V. Dzialas, R. Lubomierski, M. Hönig, T. van Eimeren (Juelich, Germany)

Functional Connectivity Subtypes Predict Longitudinal Motor Progression and Gait Disturbance in Parkinson’s Disease

S. Wang, Y. Xiao, Y. Hou, C. Li, R. Ou, J. Lin, T. Yang, Q. Jiang, X. Zheng, J. Liu, H. Shang (chengdu, China)

Genotype Matters: Vagus Nerve Atrophy in GBA-Associated Parkinson’s Disease

J. Di Giovanni, D. Genovese, G. Granata, G. Di Lazzaro, F. Tomasello, A. Cimmino, M. Patera, A. de Biase, M. Petracca, C. Piano, F. Bove, A. Bentivoglio, P. Calabresi (Rome, Italy)

Glymphatic dysfunction in patients with Parkinson’s disease is associated with regional amygdala and putamen degeneration

C. Garcia-Vicente, J. Pardo, C. Martín-Barceló, I. Roura, C. Falcon, R. Sala-Llonch, A. Campabadal, C. Uribe, N. Bargalló, O. Brengaret, C. Brenlla, C. Painous, A. Cámara, M. Buongiorno, M. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

Grey Matter Volume and White Matter Microstructural Alterations in PRKN-PD

HT. Wang, F. Xie, B. Wang, W. Luo (Hangzhou, China)

Identification of Parkinson’s Disease Tremor-Related Functional Network Topographies Using 3.0 T rs-fMRI

ZY. Lin, J. Li, ZT. Zeng, DY. Li (Lanzhou, China)

Impaired Cortical Compensation in GBA1-Associated Parkinson’s Disease

K. Steidel, M. Johansson, B. Bloem, L. Pavelka, T. Lüth, C. Pauly, E. Soboleva, S. Jónsdóttir, C. Much, S. Schaake, L. Vilas Boas, E. Thiry, G. Zelimkhanov, N. Brüggemann, C. Klein, J. Trinh, R. Krüger, R. Helmich (Nijmegen, Netherlands)

In Vivo 18F-Florzolotau Tau PET Imaging in Parkinson’s Disease with and without Probable REM Sleep Behavior Disorder

C. Xu, Y. Tang, J. Wang (Shanghai, China)

Investigating Hippocampal Subfield and Amygdala Volumes in Parkinson’s Disease with Anxiety

Y. Feuozi, C. Lambert, G. Sheehan, C. Dore, A. Schrag (London, United Kingdom)

Investigating Substantia Nigra Microstructural Integrity as a Potential Predictive Biomarker for Fall Burden in Parkinson’s Disease

I. Bedoy, J. Tejeda, R. Rajmohan, N. Phielipp (Irvine, USA)

Locus Coeruleus-Thalamic Circuit Degeneration in Parkinson’s Disease

XL. Cui, MF. Cai, YH. Zhang (Guangzhou, Guangdong Province, China)

Machine Learning–Based Brain Age Modeling Reveals Accelerated Structural Degeneration in Parkinson’s Disease

ZK. Liu, BX. Liu, MJ. Fang, N. Zhou, RT. Li, LC. He, ZT. Hu, WH. Li (Beijing, China)

Microstructural Correlates of Parkinson’s Bradykinesia

R. Benabderrazik, S. Jasaityte, C. Dore, N. Smith, G. Sheehan, C. Lambert (London, United Kingdom)

Microstructure predicts cognition after Neurostimulation in Parkinson’s disease

L. Chen, L. Witt, A. Calvano, M. Boop, C. Nimsky, H. Dafsari, L. Timmermann, M. Belke, D. Pedrosa, P. Loehrer (Marburg, Germany)

Midbrain Hypometabolism in Idiopathic REM Sleep Behavior Disorder Detected by [18F]-FDG PET as a Potential Biomarker of Nigral degeneration

A. Below, M. Ruppert-Junck, T. van Eimeren, L. Timmermann, A. Drzezga, A. Janzen, W. Oertel, D. Pedrosa (Cologne, Germany)

Mitochondrial Density Shapes Regional Vulnerability to Atrophy in Parkinson’s Disease

A. Konuri, L. Churchill, J. Anderson, A. Ignatavicius, G. Halliday, R. Landin-Romero, S. Lewis, E. Matar (Sydney, Australia)

Multimodal Quantitative MRI Improves Parkinson’s Disease Classification

P. González-Méndez, N. Castillo-Triana, C. Juri, M. Andia (Santiago, Chile)

Neural Control of Real-Time Walking in people with Parkinson’s disease

H. Sigurdsson, M. Firbank, P. Brown, C. Craig, J. Anton-Rodriguez, R. Maxwell, G. Petrides, S. Bhattacharjee, M. Bicer, S. Wallace, A. Watkins, N. Ray, N. Pavese, D. Brooks, M. Silverdale, L. Rochester, L. Alcock (San Joan de Alicante, Spain)

Neural Mechanisms of Motor Dysfunction in Idiopathic REM Sleep Behavior Disorder: An rs-fMRI Study Based on the Purdue Pegboard Test

QH. Zhang, H. Zhang, Y. Li, YK. Wang, Y. Yuan, W. Mao, P. Chan (Beijing, China)

Neuromelanin Loss Is Associated with Increased Substantia Nigra Free-Water: a Longitudinal Study of Controls, RBD, and PD

V. Madge, K. Wennberg, R. Klevor, A. Dagher, R. Postuma, D L. Collins (Montréal, Canada)

Neuromelanin-Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson’s Disease

R. Akande, T. Kustermann, S. Holiga, J. Anzures-Cabrera, G. Pagano (Welwyn Garden City, United Kingdom)

Objective Characteristics and Brain Network Alterations in Early-Stage Parkinson’s Disease with Gastric Motility Disorder

J-Y. Jin, X-Y. Cheng, C-J. Mao, C-F. Liu (Suzhou, China)

Peak Mean Skeletal Diffusivity as a Marker of Cognitive Impairment in Parkinson’s disease

W. Aye, D. Myall, T. Pitcher, S. Holdsworth, J. Dalrymple-Alford, T. Anderson, C. Le Heron, T. Melzer (Christchurch, New Zealand)

Phenoconversion from Rapid Eye Movement Sleep Behavior Disorder to Parkinson’s Disease: A multimodal Imaging Study

J. Ebina, K. Kamiya, M. Hori, M. Shibukawa, J. Nagasawa, T. Hirayama, S. Mizumura, O. Kano (Tokyo, Japan)

Posterior Cortical Hypometabolism in GBA1 Variant Carriers with and without Parkinson’s Disease

M. Avenali, R. Malito, P. Mitrotti, R. Calabrese, L. Gallo, T. Filidei, A. Panzacchi, A. Samanes Gajate, G. Pepe, R. Stiuso, M. Picascia, M. Todisco, L. Bandirali, P. Di Martino, D. Perani, A. Chiti, C. Tassorelli, E. Valente, S. Caminiti (Pavia, Italy)

Prasinezumab’s Impact on Neuromelanin- and Iron-Sensitive MRI Biomarkers in Parkinson’s disease: Findings From the PADOVA Phase IIb Study

T. Kustermann, š. Holiga, R. Akande, J. Anzures-Cabrera, N. Pross, A. Monnet, T. Nikolcheva, G. Pagano (Welwyn Garden City, United Kingdom)

Predictors of cognitive trajectories in Parkinson’s disease with mild cognitive impairment after STN-DBS: a diffusion MRI study

E. Igami, H. Takeshige-Amano, K. Takabayashi, S. Ueno, R. Kamo, D. Samayoa, W. Sako, T. Ogawa, H. Iwamuro, A. Umemura, G. Oyama, S. Aoki, K. Kamagata, N. Hattori, T. Hatano (Tokyo, Japan)

Progressive Dynamic Functional Network Disorganisation and its Association with Phenoconversion in Isolated REM Sleep Behaviour Disorder: A Multicentre Study

L. Churchill, J. Anderson, A. Ignatavicius, A. Konuri, M. Johansson, R. Gaurav, S. Lehéricy, S. Lewis, E. Matar (Sydney, Australia)

Quantitative Susceptibility Mapping Revealed Regional Iron Alteration and As a Biomarker for Dopaminergic Deficits in Parkinson’s Disease

XY. Xie, HL. Wang, YL. Du, G. Wang (Shanghai, China)

R1 from 18PR04.MZ as a Proxy for Cerebral Blood Flow in Degenerative Parkinsonism: Comparison with 15O-H2O PET/CT.

A. Damian, I. Amorin, V. Kramer, J. Higgie, I. Cordero, L. Gutierrez, E. Savio, T. Arias, O. Alonso, R. Ferrando (Montevideo, Uruguay)

Reconfiguration of Structural-Functional Coupling Associated with Clinical Features and 5-Year Progression in Parkinson’s Disease: A Cross-sectional and Longitudinal Study

Y. Li, P. He, L. Wang, K. Nie (Guangzhou, Guangdong Province, China)

Reduced Cardiac MIBG Uptake as a Biomarker for Nucleus Basalis of Meynert Degeneration and Cognitive Impairment in Parkinson’s Disease

T. Ogawa, W. Uchida, K. Kamagata, H. Takeshige-Amano, C. Andica, S. Ueno, W. Sako, S. Aoki, T. Hatano, N. Hattori (Bunkyo-ku, Japan)

Regional Basal Ganglia Hypoperfusion in Early Parkinson’s Disease: Evidence from CT Perfusion Imaging

FAY. Mallaev, GUL. Rakhimbaeva (Tashkent, Uzbekistan)

Regional Homogeneity in the Visual Network Mediates between Microbiota and Cognition in Parkinson’s Disease

S. Monti, S. Cauzzo, E. Fiorenzato, F. Vianello, P. Mariotto, G. Baruzzo, B. Di Camillo, R. Manara, A. Bertoldo, A. Antonini (Padova, Italy)

Resting-state functional network alterations in early Parkinson’s disease anxiety: a 7T MRI study

G. Carey, S. Michielse, K. Dujardin, M. Kuijf, A. Leentjens (Reims, France)

Resting-state network reorganization following multimodal lifestyle intervention in Parkinson’s disease

A. Aali, J. Kelly, M. Powell, R. Cloke, A. Hashimoto, Y. Wang, A. Kuan, D. Darabi, T. Watson, J. Yu, S. Dhaliwal, K. Pressman-Cyna, M. Williams, M. Paventi, R. Hassen, O. Brigden, J. Stoessl, V. Sossi, M. Mckeown, S. Appel-Cresswell (Vancouver, Canada)

Resting-state pupil fluctuations reflect monoaminergic brainstem dysfunction associated with non-motor symptoms in early Parkinson’s disease

L. Negri, P. Kinz, S. Bokern, V. Buffler, K. Geiger, I. Uras, B. Popa, J. Conrad (Mannheim, Germany)

Semiquantitative [¹²³I]FP-CIT SPECT metrics combined with machine learning improve clinical differentiation of parkinson’s disease and atypical parkinsonian syndrome

P. Fernandez-Rodriguez, P. Franco-Rosado, P. Diaz-Galvan, L. Muñoz-Delgado, A. Luque- Ambrosiani, JA. Lojo-Ramírez, D. García Solis, M. Grothe, P. Mir (Seville, Spain)

Sequential neurodegenerative trajectories across the onset of mild parkinsonian signs in isolated REM sleep behavior disorder: a longitudinal multimodal imaging study

R. Kim, H. Kim, Y. Kim, J. Lee (Seoul, Republic of Korea)

Spatiotemporal Trajectories of Plasma Biomarkers and Diffusion MRI Metrics in Parkinson’s Disease

S. Ueno, H. Takeshige-Amano, S. Miyaguchi, K. Takabayashi, Y. Yada, Y. Kondo, D. Samayoa, E. Igami, T. Ogawa, S. Ueno, W. Sako, T. Tateishi, T. Hoshino, K. Kamagata, N. Hattori, N. Honda, T. Hatano (Tokyo, Japan)

Specific thalamic subnuclei volumes associate with autonomic dysfunction in Parkinson’s disease

S. Haji, W. Sako, K. Takabayashi, K. Kamagata, T. Hatano, N. Hattori (Bunkyo-ku, Japan)

Structural-Functional Coupling Supporting Motor Reserve in Early-Stage Parkinson’s Disease

Y. Li, P. He, L. Wang, K. Nie (Guangzhou, Guangdong Province, China)

Structural-Functional Decoupling and Imaging Transcriptomics in Cognitive Impairment of Parkinson’s Disease

C. Liu, Y. Zhu, L. Yang, X. Yang (kunming, China)

Subregional Striatal Dopaminergic Deficits, Cerebral Hypoperfusion and Cognitive Impairment in Parkinson’s Disease

XY. Xie, YL. Du, HL. Wang, G. Wang (Shanghai, China)

Substantia nigra neuromelanin magnetic resonance imaging in LRRK2 asymptomatic carriers

V. Carvalho, J. Freitas, C. Guerreiro, D. Cruz, C. Correia Rodrigues, A. Travessa, R. Barreto, A. Valadas, P. Pita Lobo, M. Grunho, R. Simões, M. Rosa, M. Coelho, A. Mendes, J J. Ferreira, S. Reimão, L. Correia Guedes (LISBOA, Portugal)

Subthalamic Nucleus Deep Brain Stimulation Impact on Language Network Connectivity

D. Lench, E. Laramie, M. Sowlat, G. Revuelta, F. Rodriguez-Porcel (Charelston, USA)

Subthalamic Nucleus Deep Brain Stimulation Modulates Cortical Activation During Kinesthetic Illusion in Parkinson’s Disease: An fMRI Study

A. Vijayakumari, T. Gonzalez, C. Piccinin, P. Bhattacharyya, M. Lowe, B. Walter (Cleveland, USA)

Subtype-specific alterations of iron deposition and neuromelanin loss in the substantia nigra of Parkinson’s disease

A. Shima, Y. Sakato, R. Sakai, Y. Terada, D. Kambe, A. Nishida, K. Yoshimura, H. Sakamaki, I. Wada, M. Sawamura, E. Nakanishi, H. Yamakado, S. Okuchi, T. Okada, Y. Fushimi, Y. Nakamoto, R. Takahashi, R. Matsumoto, N. Sawamoto (Kyoto, Japan)

The Diagnostic Value of Dopaminergic-Glucose United PET Imaging in Parkinson’s disease

XY. Li, JY. Lu, FT. Liu, CT. Zuo, JW. Wang (Shanghai, China)

The Dual Functional Organization of the Substantia Nigra in Parkinson’s Disease

M. Passaretti, D. Vereb, B. Zufiria-Gerbolés, M. Mijalkov, M. Veronese, J B. Pereira (Stockholm, Sweden)

The predictive value of the 18F-FDG PET-derived Parkinson’s disease Related Pattern for neurodegenerative disease progression in isolated REM Sleep Behavior Disorder

A. Dortmond, S. Lövdal, G. Carli, K. Leenders, K. Reetz, S. Schawohl, D. Arnaldi, B. Orso, S. Morbelli, A. Janzen, W. Oertel, D. Perani, L. Ferini-Strambi, A. Galbiati, C. Liguori, A. Chiaravalloti, M. Carpi, J. Lee, R. Kim, S. Meles (Ann Arbor, USA)

The Relationship Between Substantia Nigra Hyperchogenicity and Clinical Features and Disease Progression in Parkinson’s Disease Patients

WJ. Hu, HH. Luan (Yantai, China)

The Transcriptomic, Neurotransmitter, and Cell Type Signatures Underlying Pure Fatigue in Early-stage Parkinson’s Disease

Y. Xiao, S. Wang, Y. Hou, R. Ou, C. Li, W. Song, X. Shi, X. Zhu, H. Shang (Chengdu, China)

Therapeutic effects of intermittent theta-burst stimulation on motor, non-motor symptoms and functional connectivity in de novo Parkinson’s disease

R. Rashid-López, P. Macías-García, AJ. Cruz-Gómez, FL. Sánchez-Fernández, E. Sarrias-Arrabal, F. Cano-Cano, M. García-Corrales, R. Martínez-Regueiro, M. Melcón-Martín, F. Sanmartino, R. Espinosa-Rosso, JJ. González-Rosa (Cádiz, Spain)

Topographic Heterogeneity of Dopaminergic Denervation and Iron Deposition in Functional Subregions of Nigrostriatal System in Parkinson’s Disease

YJ. Duan, XL. Liu, XJ. Dan, Y. Li, H. Zhang, HW. Qiao, W. Mao, EH. Xu, SY. Liu, P. Chan (Beijing, China)

Toward Objective Monitoring of Motor Fluctuations in Parkinson’s Disease: TMS-EEG Biomarkers

T. Fay-Karmon, T. Davidy, A. Suminski, A. Saar, N. Zifman, N. Fogel, S. Hassin-Baer (Ramat Gan, Israel)

Visualization of Small Brainstem Nuclei With the Ultra-High Performance NeuroEXPLORER PET Camera: a Comparison Study Using 18F-AV133

N. Prakash, R. Gunn, G. Rizzo, G. Searle, Z. Fan, J. Eberling, G. Tamagnan, J. Seibyl, K. Marek (New Haven, USA)

White Matter Hyperintensity and the Spatial Subtypes in Parkinson’s Disease

XY. Xie, HL. Wang, YL. Du, G. Wang (Shanghai, China)